For the prevention of rheumatoid arthritis to become feasible, it may be necessary to intervene as soon as possible in the pre-RA course, although the specific timing remains unclear, according to a ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Rheumatoid arthritis prevention in patients at the subclinical or pre-clinical stage remains ...
Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...
Studies designed to shed light on the prediction of rheumatoid arthritis (RA) are showing substantial promise -- not only for RA but a host of other rheumatic diseases. Rheumatology care professionals ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Rheumatoid arthritis has traditionally been framed as a self-contained autoimmune disease confined to joints, yet mounting clinical and molecular evidence now argues that it functions as a hub within ...
Rheumatoid arthritis (RA) is a chronic, incurable disorder, so treatment focuses on managing the disease and controlling its progression. Although current treatments help control RA symptoms in most ...
A new therapeutic approach for rheumatoid arthritis (RA) could help prolong the time between flare-ups and even prevent the onset of the disease in at-risk patients. This is the promise of a new study ...
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results